Middle East Regulatory Policy Brief

Covering Healthcare, Medical Device, Recall, Urology, Cesarean Section. Explore critical regulatory developments in Healthcare, Medical Device recalls, Urology service standards, and Cesarean Section governance across the UAE and Bahrain. Stay informed on compliance and safety mandates impacting these sectors.

Show Notes

This episode covers significant regulatory updates impacting the Healthcare and Financial sectors in the Middle East, including new mandates on medical procedures, device safety, and service standards.

Key highlights include the UAE Department of Health's introduction of mandatory consultations and strengthened governance for cesarean sections, requiring documented informed consent, standardized classification of procedures, and senior clinical oversight for non-emergency cases. Another vital update mandates healthcare facilities offering urology and andrology services to provide dedicated sample collection rooms that ensure privacy, hygiene, and infection control compliance.

The episode also discusses a safety alert on counterfeit weight loss products containing potentially harmful ingredients, urging vigilance and reporting. Additionally, a medical devices field safety alert outlines recalls and corrective actions manufacturers must communicate to users.

On the financial front, Bahrain's Central Bank approved audited financial statements and reinforced supervisory measures to maintain financial stability amid regional developments.

For more information, visit the Carver Agents website.

Articles mentioned:
  1. Mandatory Consultation on the Birth Plan and Strengthening the Governance of Cesarean Section Procedures
  2. Mandatory Requirements for Urology & Andrology Samples Collection
  3. 欧盟对华丙烯酸酯发起反倾销调查
  4. Alert Against Use of Counterfeit Weight Loss Products
  5. Medical Devices Field Safety Alert
  6. CBB holds first Board meeting for 2026

What is Middle East Regulatory Policy Brief?

Regulatory news, updates, and insights for countries in the Middle East presented by the Carver Agents team

Welcome to Carver's Middle East Regulatory Updates for March 22, 2026.

Starting in the United Arab Emirates, the Department of Health has introduced mandatory consultation requirements on birth plans and strengthened governance of cesarean section procedures. Healthcare providers must now conduct structured antenatal counselling that includes vaginal birth after cesarean, or VBAC, and provide documented informed consent. All cesarean sections require clear, evidence-based clinical justification recorded at the time of decision. Additionally, cesarean sections must be classified using standardized urgency categories from one to four, as well as the Robson Ten-Group Classification system. Senior clinical oversight is mandated for all non-emergency primary cesarean procedures.

Also in the United Arab Emirates, healthcare facilities offering urology and andrology services must now provide dedicated sample collection rooms. These rooms must meet strict privacy, hygiene, and procedural standards. Requirements include at least one on-site sample collection room with complete visual and auditory privacy, lockable doors, and separation from public or high-traffic areas. The rooms must be maintained according to infection prevention and control standards.

The UAE Department of Health has issued a warning against the use of counterfeit weight loss products that are not registered with the Emirates Drug Establishment. These counterfeit products, some claiming to contain GLP-1 receptor agonists, pose significant health risks due to undisclosed harmful ingredients and lack of medical benefit. Healthcare professionals and the public are urged to report any complaints or adverse reactions related to these products to the Pharmacovigilance program. The Department emphasizes that only products registered with the Emirates Drug Establishment and used under medical supervision should be considered safe.

In addition, the UAE Department of Health released a medical devices field safety alert. This circular includes recalls, safety notifications, product corrections, and discontinuations for various medical devices from multiple manufacturers. Manufacturers are required to provide Field Safety Notices and Field Safety Corrective Actions to users. Healthcare professionals must follow manufacturer instructions carefully and report any adverse events related to these devices.

Turning to Bahrain, the Central Bank of Bahrain held its first board meeting for 2026. The board approved the audited financial statements for 2025 and reviewed key financial indicators through early 2026. It affirmed strengthened supervisory measures in response to regional developments. The Central Bank of Bahrain emphasized maintaining strong financial soundness indicators, ensuring efficient and secure operation of financial and payment systems, and continuing coordination with banks, insurance companies, and financial institutions to guarantee service continuity.

That wraps up today's regulatory updates. Visit carveragents.ai for more information.